Treatments

The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.

You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.

Become a Partner.

Country Product Indication Sponsor Date
Octreotide VIPoma Novartis Pharmaceuticals Corporation;59 Route 10;East Hanover, New Jersey, 07936 August 24, 1998
Octreotide Severe diarrhea and flushing associated with malignant carcinoid tumors Novartis Pharmaceuticals Corporation;59 Route 10;East Hanover, New Jersey, 07936 August 24, 1998
Octreotide Acromegaly Novartis Pharmaceuticals Corporation;59 Route 10;East Hanover, New Jersey, 07936 August 24, 1998
Botulinum toxin type A Spasmodic torticollis (cervical dystonia) Ipsen Biopharm Limited;1 Bath Road, Maidenhead;Berkshire, SL6 4UH August 12, 1998
Aldesleukin Acute myeloid leukemia Chiron Corporation;4560 Horton St.;Emeryville, California, 94608 July 31, 1998
Thalidomide Kaposi sarcoma Celgene Corporation;7 Powder Horn Dr.;Warren July 29, 1998
Epratuzumab Non-Hodgkin's lymphoma Immunomedics, Inc.;300 The American Road;Morris Plains, New Jersey, 07950 July 13, 1998
Recombinant human Clara Cell 10kDa protein Bronchopulmonary dysplasia Therabron Therapeutics, Inc.;9430 Key West Avenue, Suite 150;Rockville, Maryland, 20850 July 13, 1998
Peginterferon alfa-2a Renal cancer Hoffman-La Roche Inc.;340 Kingsland St.;Nutley, New Jersey, 07110 July 13, 1998
Alpha-galactosidase A Fabry disease Shire Human Genetic Therapies, Inc.;700 Main Street;Cambridge, Massachusetts, 02139 June 22, 1998
Recombinant bactericidal/permeability-increasing protein Severe meningococcal disease Xoma (US) LLC;2910 Seventh Street;Berkeley, California, 94710 June 22, 1998
Prostaglandin E1 enol ester (AS-013) Fontaine Stage IV chronic critical limb ischemia LTT Baio-Pharma Co., Ltd;Research & Development Division, 2-5-1 Atago, Minato-ku, Tokyo; June 12, 1998
Liposomal N-Acetylglucosminyl-N-Acetylmuramly-L-Ala-D-isoGln-L-Ala -gylcerolidpalmitoyl Pediatric osteosarcoma Endorex Corp.;900 North Shore Drive;Lake Bluff, Illinois, 60044 June 10, 1998
Liposomal N-Acetylglucosminyl-N-Acetylmuramly-L-Ala-D-isoGln-L-Ala -gylcerolidpalmitoyl Ewing's sarcoma Endorex Corp.;900 North Shore Drive;Lake Bluff, Illinois, 60044 June 10, 1998
Fructose-1,6-diphosphate Sickle cell anemia Questcor Pharmaceuticals, Inc.;3260 Whipple Road;Union City, California, 94587 May 29, 1998
Benzydamine hydrochloride Prophylactic treatment of oral mucositis resulting from radiation therapy for head and neck cancer Angelini Pharmaceuticals, Inc.;70 Grand Avenue;River Edge, New Jersey, 07661 May 18, 1998
Ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate Crohn's disease Tap Holdings Inc.;2355 Waukegan Road;Deerfield, Illinois, 60015 May 13, 1998
1,5-(Butylimino)-1,5 dideoxy,D-glucitol Fabry disease Oxford GlycoSciences;10, The Quadrant, Abington Science Park;United Kingdom May 12, 1998
Amifostine Reduction of the incidence of moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer Medimmune Oncology, Inc.;One Tower Bridge, 100 Front St., Suite 400;West Conshohocken, Pennsylvania, 19428 May 12, 1998
Tetrabenazine Moderate/severe tardive dyskinesia Prestwick Pharmaceuticals, Inc.;1825 K Street, NW, Suite 1475;Washington, District of Columbia, 20006 May 12, 1998
Liposomal cyclosporin A For aerosolized administration in the prevention and treatment of lung allograft rejection and pulmonary rejection events associated with bone marrow transplantation Vernon Knight, M.D.;Baylor College of Medicine, Dept. of Molecular Phy, One Baylor Plaza;Houston, Texas, 77030 April 30, 1998
S-adenosylmethionine AIDS-myelopathy Genopia USA, Inc.;90 Gold Street, 6N;New York, New York, 10038 April 30, 1998
Sodium phenylbutyrate For use as an adjuct to surgery, radiation therapy and chemotherapy for the treatment of patients with primary or recurrent malignant glioma Elan Drug Delivery, Inc.;1300 Gould Dr.;Gainesville, Georgia, 30504 April 24, 1998
Tiapride Tourette syndrome Sanofi-Synthelabo, Inc.;9 Great Valley Parkway, PO Box 3026;Malvern, Pennsylvania, 19355 April 21, 1998
Tacrolimus Prophylaxis of graft-versus-host-disease Fujisawa USA, Inc.;3 Parkway North Center;Deerfield, Illinois, 60015 April 6, 1998